$ACT Up to date company activities and other impor

$ACT Up to date company activities and other important information about $ACT

$ACT

DD Notes ~ http://www.ddnotesmaker.com/ACT

##### recent news/filings ~ source: finance.yahoo.com

Thu, 15 May 2014 13:15:15 GMT ~ Eli Lilly loses UK Alimta patent case to Actavis
- * UK court rules Actavis (NYSE: ACT - news) can launch generic version of drug * Lilly says plans to appeal setback for lung cancer drug (Adds quote from Lilly legal counsel, analyst comment) LONDON, May 15 (Reuters) - Eli Lilly and Co said on Thursday it lost a patent case in the English High Court over its blockbuster Alimta lung cancer drug to generic drugmaker Actavis Plc. The court ruled that Actavis would not infringe patents held by Lilly if it marketed certain alternative salt forms of the drug, known generically as pemetrexed, in Britain and several other European countries in 2015.
read full: http://uk.finance.yahoo.com/news/eli-lilly-lo...58683.html
*********************************************************

Thu, 15 May 2014 13:02:20 GMT ~ Actavis has reached attractive entry point, says RBC Capital
read full: http://www.theflyonthewall.com/permalinks/ent...BC-Capital
*********************************************************

Thu, 15 May 2014 12:47:24 GMT ~ Actavis extends exclusive agreement to distribute authorized generic Concerta
read full: http://www.theflyonthewall.com/permalinks/ent...c-Concerta
*********************************************************

Thu, 15 May 2014 12:46:00 GMT ~ 8:46 am Actavis extends exclusive agreement to distribute authorized generic Concerta
read full: http://finance.yahoo.com/news/inplay-briefing...7.html#act
*********************************************************

Thu, 15 May 2014 12:45:00 GMT ~ Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta®
- DUBLIN, May 15, 2014 /PRNewswire/ -- Actavis plc (ACT) today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. (JPI) to continue supplying the authorized generic version of JPI's Concerta® (methylphenidate hydrochloride extended-release tablets). Under the terms of the extended exclusive supply and distribution agreement — which was first agreed to by the companies in November 2010 and due to expire on December 31, 2014 — JPI will continue to manufacture and supply Actavis with all dosage strengths of the authorized generic product, and Actavis will continue to market and distribute the product in the United States. JPI will receive 50 percent of the net sales from Actavis' product. The extended agreement runs until December 31, 2017. During the term of the agreement, Actavis may continue to pursue U.S. Food and Drug Administration approval of its abbreviated new drug application (ANDA) for a generic version of Concerta® and may launch its own ANDA product at the conclusion of the exclusive supply agreement.
read full: http://finance.yahoo.com/news/actavis-extends...00575.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=ACT&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=ACT&a...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ACT/company-info
Ticker: $ACT
OTC Market Place: Not Available
CIK code: not found
Company name: Actavis plc
Incorporated In:

##### extra dd links

Latest filings: http://www.otcmarkets.com/stock/ACT/filings
Latest financials: http://www.otcmarkets.com/stock/ACT/financials
Latest news: http://www.otcmarkets.com/stock/ACT/news - http://finance.yahoo.com/q/h?s=ACT+Headlines

Major holdings: http://data.cnbc.com/quotes/ACT/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ACT+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ACT.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ACT

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Actavis+plc&x=...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Actavis+plc
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

Short Sales: http://www.otcmarkets.com/stock/ACT/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ACT/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ACT/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ACT+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ACT+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ACT+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ACT+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ACT+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ACT+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ACT
Balance Sheet: http://finance.yahoo.com/q/bs?s=ACT
Cash Flow: http://finance.yahoo.com/q/cf?s=ACT+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ACT
Bloomberg: http://www.bloomberg.com/quote/ACT:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ACT
Bussinessweek: http://investing.businessweek.com/research/st...ticker=ACT
Barchart: http://www.barchart.com/quotes/stocks/ACT
OTC Short Report: http://otcshortreport.com/index.php?index=ACT
Investopedia: http://www.investopedia.com/markets/stocks/ACT/?wa=0

http://www.pennystocktweets.com/stocks/profile/ACT

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/ACT